Stand out for this role — generate a tailored resume and cover letter in about a minute.
Queen Mary University of London invites a Senior Trials Manager to lead multi-site CTIMP activities for the ChariotMS study, a phase IIb efficacy trial of cladribine tablets, with cost-utility analysis. The role spans the Centre for Evaluation and Methods within WIPH, engaging NHS participants and coordinating trial sites across the UK.
The ideal candidate has proven trial management experience in CTIMPs, strong organisational skills, and a track record of delivering trials in complex settings.
Opportunity ID
11416
Faculty
Medicine & Dentistry
Location
QM London
Contract Type
Fixed Term
Duration
9 months
Working Patterns
Full Time
Full Time Equivalent (FTE)
1.00
Salary Range
£44,288-£51,755 per annum
Job Pack
Opportunity 11416 - Senior Trials Manager (ChariotMS) - JP.pdf - 866KB Opens in a new window
Contact Details
Informal enquiries should be addressed to Harpreet Kaur Pawar (h.pawar@qmul.ac.uk).
Informal enquiries about ChariotMS should be addressed to Professor Klaus Schmierer (k.schmierer@qmul.ac.uk).
This post represents an ideal opportunity for a self-motivated, experienced Trial Manager/Senior Trial Manager to work in a multi-site CTIMP trial in a registered Clinical Trials Unit.
ChariotMS is a national (UK), multi-centre, randomised, double-blind, placebo-controlled (1:1) phase IIb efficacy trial with cost-utility analysis of cladribine tablets (3.5mg/kg over two years) in people with advance multiple sclerosis (EDSS 6.5-8.5). Is cladribine superior to placebo in protecting upper limb function?
Previous research experience in multi-site Clinical Trials of an Investigational Medicinal Product (CTIMPs) involving NHS patients or research participants is essential.
The Wolfson Institute of Population Health (WIPH) is an exciting and dynamic environment, home to more than 450 staff, 100 PhD students and c500 postgraduate taught students. It harnesses expertise across a wide range of population-based research and education activities and aims to be an internationally recognised centre of excellence in population health, primary care and preventive medicine. The Institute is organised into six separate research centres which, though complementary and following the Institute strategic plan, also have Centre-specific objectives and requirements.
The post-holder will work in the Centre for Evaluation and Methods (CEM), a thriving centre that incorporates collaborative units who work to deliver outstanding research based on their combined and complementary strengths. The post-holder will contribute in particular to the Pragmatic Clinical Trials Unit (PCTU).
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we've fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it's simply 'the right thing to do' but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
We offer competitive salaries, access to a generous pension scheme, 30 days' leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
Queen Mary's commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
16/10/2026, 23:55